Boris Jordan

Curaleaf (OTCQX: CURLF), one of the largest cannabis companies in the world, plans to start selling marijuana for recreational purposes by the end of 2024 in Germany, where the recreational cannabis market is expected to grow significantly, especially after last week...

"Think back to really any cyclical industry or any consumer-driven industry where there are moments of excess and growth and contraction of that growth," Camilo Lyon, chief investment officer at Curaleaf Holdings Inc (OTCQX: CURLF), began his talk at the recent Benzinga Cannabis...

Price pressure has been a common theme in this past week's round of cannabis earnings. While Curaleaf Holdings Inc. (OTCQX: CURLF) was no exception, the company reported a positive second quarter with revenue at $339 million - a 4% YoY growth, which met street...

Curaleaf Holdings (OTCQX: CURLF reported its financial and operating results Wednesday afternoon for the second quarter ended June 30, 2023.  Boris Jordan, executive chairman seemed delighted as Curaleaf's revenue grew 4% YoY to $339 million with an adjusted...

Amsterdam's Red Light District will no longer allow marijuana smoking on its streets starting May 25. Any violation of the new law, which will be enforced by police as well as local officials, will be punishable by a €50 (or $54) fine. Nevertheless, tourists seem to be undeterred...

Curaleaf Holdings Inc. (CSE: CURA) (OTC: CURLF) released its financial results for the first quarter ended March 31, 2023. Q1 2023 Financial Highlights Net Revenue of $336.5 million, a year-over-year increase of 14% compared to Q1 2022 revenue of $296 million, which excludes discontinued...

Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE:CURA) released its financial and operating results for the fourth quarter and year ended December 31, 2022, revealing net revenue of $1.336 billion, a 12% increase compared to $1.195 billion in FY 2021. Full Year 2022 Financial Highlights Gross profit...

Regulators in New Jersey dealt a major setback to Curaleaf Holdings Inc (OTCQX: CURLF), the state's leading cannabis company, by denying its request for a license renewal to cultivate and sell recreational marijuana. According to New Jersey Monitor, the unexpected vote left observers...

Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX: CURLF) announced the completion of its acquisition of Deseret Wellness. With the close of the transaction, Curaleaf's retail footprint has increased to four dispensaries in Utah and 150 nationwide. Boris Jordan, executive chairman of Curaleaf, stated...

Boris Jordan of Curaleaf Holdings Inc (OTC: CURLF) spoke at the Benzinga Cannabis Capital Conference in 2022 and expressed his excitement for the potential of the European market for cannabis. He specifically mentioned the UK, which he claimed had the best medical law he had seen anywhere in the...

Russian billionaire and a former owner of the Chelsea Football Club, which plays in the English Premier League, Roman Abramovich, has been secretly investing in cannabis companies for years. According to leaked documents, sourced and shared by Forensic News, a Russian...

New Jersey Senator Cory Booker thinks that Senate minority leader Mitch McConnell is significantly impacting his Senate colleagues to oppose passing any cannabis-related bills in the lame-duck session. Last week, McConnell revealed he was pleased that the final version of the National Defense...

Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE:CURA) released its financial and operating results for the third quarter ended September 30, 2022, revealing total revenue increased by 7% to $340 million during the third quarter of 2022, compared to $317 million in the third quarter of 2021. The company...

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) completed its previously announced acquisition of Tryke Companies (dba as Reef Dispensaries), a privately held vertically integrated, multi-state cannabis operator. With the close of the transaction, Curaleaf's...

Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE:CURA) completed its agreement to acquire a 55% stake in Four 20 Pharma GmbH, a fully EU-GMP & GDP licensed German producer and distributor of medical cannabis. Boris Jordan, executive chairman of Curaleaf, stated, "We are pleased to complete the...